Nuvalent
ID: 7393920Nuvalent is creating precisely targeted therapies for patients with cancer.
2
Funding Rounds
$185.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| An** Pr******** | - | - | |
| Em*** Dr***** Co**** | - | - | - |
| Ma***** D. Sh*** | - | - | - |
| Ca***** Wh***** | - | - | - |
| Jo**** Pe******* | - | - | - |
| An**** Ha** | - | - | - |
| Ga** Gi******* | - | - | - |
| Sa*** Sr******** | - | - | - |
| Ja*** Po**** (e************ | - | - |
Funding series
Funding Series Analysis
The company Nuvalent has raised a total of $185m in funding over 2 rounds.
Key Insights:
- Nuvalent Series B round, May 2021: $135m
- Nuvalent , January 2021: $50m
Industries
Nuvalent is active in the following industries: